Arcellx, Inc. Share Price
Stocks
ACLX
US03940C1009
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 28/04/2026 am IST
|
5-day change | 1st Jan Change | ||
| 115.07 USD | +0.03% |
|
-.--% | +76.49% |
| 08/05 | Gilead Sciences Expects Loss This Year on Acquired R&D Expenses | DJ |
| 08/05 | Gilead raises 2026 sales forecast, flags profit hit from acquisitions | RE |
| Market Cap | 675.14Cr 583.12Cr 548.64Cr 498.64Cr 937.87Cr 65TCr 951.62Cr 6.44TCr 2.52TCr 32TCr 2.53TCr 2.48TCr 1,07800Cr | P/E 2024 |
-38.3x | P/E 2025 | -16x |
|---|---|---|---|---|---|
| Enterprise Value | 628.33Cr 542.69Cr 510.6Cr 464.07Cr 872.84Cr 60TCr 885.63Cr 5.99TCr 2.35TCr 30TCr 2.36TCr 2.31TCr 1,00300Cr | EV / Sales 2024 |
3,31,25,319x | EV / Sales 2025 | 14,81,61,186x |
| Free-Float |
88.44% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Arcellx, Inc.
| 1 day | +0.03% | ||
| 6 months | +66.67% | ||
| Current year | +76.49% |
| Current year | 60.36 |  | 115.13 |
| 1 year | 60.36 | | 115.13 |
| 3 years | 30.88 | | 115.13 |
| 5 years | 6.04 | | 115.13 |
| 10 years | 6.04 | | 115.13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/04/26 | Issuer sale | Director | 28,644 | 0.0490% | ||
| 27/02/26 | Fiscal year | Chief Executive Officer | 2,54,464 | 0.4401% | ||
| 25/02/26 | Fiscal year | Chief Financial Officer | 31,749 | 0.0549% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | -.--% | +60.22% | +230.85% | 675.14Cr | |
| -0.11% | -1.67% | +1.80% | +19.90% | 4.88TCr | |
| +1.89% | +5.08% | +492.59% | +629.24% | 4.54TCr | |
| +1.83% | +2.75% | +15.61% | +91.22% | 4.12TCr | |
| -0.50% | -1.56% | +24.67% | +12.17% | 3.97TCr | |
| -2.74% | -7.13% | +18.72% | +49.04% | 3.26TCr | |
| -1.14% | -2.51% | +27.52% | +136.42% | 1.67TCr | |
| +0.59% | -2.25% | - | - | 1.62TCr | |
| -0.49% | -0.34% | +3.45% | +29.14% | 1.41TCr | |
| -2.60% | -1.00% | +77.85% | +40.37% | 1.37TCr | |
| Average | -0.32% | -0.79% | +80.27% | +137.60% | 2.75TCr | |
| Weighted average by Cap. | -0.02% | -0.39% | +103.03% | +155.22% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 107.94 93.22 87.71 79.72 149.94 10.34T 152.14 1.03T 403.22 5.17T 405.25 396.45 17.23T | 22.29 19.25 18.11 16.46 30.96 2.14T 31.41 212.44 83.25 1.07T 83.67 81.86 3.56T |
| Net income | -11Cr -9.27Cr -8.72Cr -7.93Cr -15Cr -1.03TCr -15Cr -102.33Cr -40Cr -514.42Cr -40Cr -39Cr -1.71TCr | -23Cr -20Cr -19Cr -17Cr -32Cr -2.19TCr -32Cr -218.23Cr -86Cr -1.1TCr -86Cr -84Cr -3.65TCr |
| Net Debt | -57Cr -49Cr -46Cr -42Cr -79Cr -5.48TCr -81Cr -544.84Cr -213.52Cr -2.74TCr -214.6Cr -209.94Cr -9.12TCr | -47Cr -40Cr -38Cr -35Cr -65Cr -4.49TCr -66Cr -446.24Cr -174.88Cr -2.24TCr -175.76Cr -171.94Cr -7.47TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ACLX Stock
Select your edition
All financial news and data tailored to specific country editions
